Aspects on gender, quality of life and diastolic function in patients with cardiovascular disease and type 2 diabetes by Venskutonyte, Laura
Karolinska Institutet, Department of Medicine, Cardiology Unit, 
Karolinska University Hospital, Stockholm, Sweden
Aspects on gender, quality of life and 
diastolic function in patients with 
cardiovascular disease and type 2 diabetes
AKADEMISK AVHANDLING
som för avläggande av medicine doktorsexamen vid Karolinska Institutet 
offentligen försvaras i Thorax Aula, Karolinska Universitetssjukhuset i Solna, 
fredagen den 22/3 2013 klockan 09.00
av 
Laura Venskutonyte
Fakultetsopponent
Professor Oliver Schnell
Ludwig-Maximilians Universität Munchen
Neurochirurgische klinik
Betygsnämnd
Docent Tomas Jernberg
Karolinska Institutet
Institutionen för medicin, Huddinge
Enheten för kardiologi
Docent Soffia Gudbjörnsdottir
Göteborgs universitet
Institutionen för medicin, Sahlgrenska
Molekylär och klinisk medicin
Docent Bruna Gigante
Karolinska Institutet
IMM Institute of Environmental Medicine
Huvudhandledare 
Med Dr Barbro Kjellström
Karolinska Institutet
Institutionen för medicin, Solna
Enheten för kardiologi
Bihandledare 
Professor emeritus Lars Rydén
Karolinska Institutet
Institutionen för medicin, Solna
Enheten för kardiologi
Med Dr Christina Jarnert
Karolinska Institutet
Institutionen för medicin, Solna
Enheten för kardiologi
Professor John Öhrvik
Karolinska Institutet
Institutionen för medicin, Solna
Enheten för kardiologi
Stockholm 2013
ABSTRACT
ISBN 978-91-7549-016-8
Background
A majority of patients with type 2 diabetes mellitus (T2DM) suffer and die from a cardiovascular 
disease (CVD). Because of the increasing prevalence of diabetes, it today rivals smoking, hypertension 
and hypercholesterolemia as a major risk factor for CVD resulting in a need for more attention and 
further investigations.
Aims
In patients with T2DM to
1.  explore the role of gender on the development of cardiovascular (CV) events and mortality following 
acute myocardial infarction (MI) 
2.  analyse the association between self-reported health and survival after acute MI
3.  investigate if insulin therapy influences treatment satisfaction and psychological well-being in 
patients surviving acute MI
4.  assess the progress of early signs of left ventricular (LV) diastolic dysfunction 
Prognosis after acute MI
Eight hundred thirty seven men and 416 women with T2DM and acute MI were followed for a median 
of 2.1 years. Women were older and had higher prevalence of concomitant diseases compared with 
men. Total mortality did not differ between the genders. The combined endpoint of death and non-fatal 
MI or stroke was more common among women than men (39% vs. 32%, p=0.012). The difference 
disappeared after adjusting for age.
Predictive power of self-rated health
Prospective associations between self-rated health reported by Rating Scale (RS) and all-cause 
mortality, CV death and CV events were assessed in 465 patients with T2DM and acute MI. The RS 
score predicted CV events (HR; 95% CI 0.87; 0.80-0.95) and all-cause mortality (0.86; 0.76-0.97) in 
unadjusted analyses. Corresponding HR after adjustment for potential confounders were 0.90; 0.83-
0.99 and 0.90; 0.79-1.02 respectively.
Satisfaction with treatment and psychological well-being
To determine effects of insulin-based treatment the Diabetes Treatment Satisfaction Questionnaire 
(DTSQ) and the Psychological General Well-being index (PGWB) were administered to 324 patients 
with T2DM and acute MI at baseline and after 12-months. Insulin treated patients (n=197) had a worse 
risk profile and more co-morbidity at baseline than patients on oral glucose lowering agents (n=127). 
Insulin-based therapy was well accepted. Treatment satisfaction and psychological well-being were 
similar between patients treated with insulin and oral drugs at baseline. It improved significantly in both 
groups and remained similar at 12-months. 
Left ventricular diastolic function in patients with T2DM
Paired data from 73 patients with T2DM and no apparent CVD was available for assessment of LV 
diastolic function. At baseline LV diastolic dysfunction was observed in 38 patients (52%). During 
follow-up it normalized in 20 (53%) of these patients and remained unchanged in 18 (47%). Of 35 
(48%) patients with normal LV diastolic function at baseline 8 (23%) patients developed dysfunction. 
Conclusions
Diabetes specific risk factors contribute to coronary artery disease and impaired myocardial function. 
Better understanding of the aspects of gender and quality of life may help to identify patients at risk for 
CV events and mortality and improve their outcomes. Insulin treatment had similar acceptance as oral 
glucose lowering treatments among patients with T2DM and established CVD and could be started as 
needed without adding any burden to the patient. Progression of LV diastolic function in patients with 
T2DM and no other CVD seems to be slower than earlier described and might even regress over time.
